Aster Capital Management’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.17K Buy
+598
New +$11K ﹤0.01% 788

Other funds holding AVTX

Aster Capital Management's AVTX Position: Q3 2026 in Review

Aster Capital Management opened a new position in Avalo Therapeutics (AVTX) in Q3 2026: 598 shares worth $9.17K. The stake represents ﹤0.01% of the portfolio and ranks #788 among its holdings.

148 funds tracked by Wall St. Rank hold AVTX as of Q3 2026.

  • Aster Capital Management held 598 shares of Avalo Therapeutics worth $9.17K as of Q3 2026.
  • Avalo Therapeutics was a new Aster Capital Management position in Q3 2026.
  • Avalo Therapeutics made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #788 holding.
  • 148 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.